Constitutively active mutant N111G of angiotensin II type 1 (AT 1) receptor induces homologous internalization through mediation of AT1-receptor antagonist

Journal of Pharmacological Sciences

Volumn 111, Issue 3, 2009, Pages 227-234

  Bhuiyan, Mohiuddin Ahmed ^a   Hossain, Murad ^a   Miura, Shin Ichiro ^b   Nakamura, Takashi ^a   Ozaki, Masanobu ^a   Nagatomo, Takafumi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Binding affinity; Constitutive activity; Internalization; Inverse agonist activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; CONSTITUTIVELY ACTIVE MUTANT N111G RECEPTOR; INOSITOL PHOSPHATE; LOSARTAN; TELMISARTAN; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS7; CONTROLLED STUDY; ENDOCYTOSIS; INTERNALIZATION; NONHUMAN; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 73349124790     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09202FP     Document Type: Article

References (39)

1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001;291:1304-1351.
2. Whitebread S, Mele M, Kamber B, DeGasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;163:284-291.
3. Chiu AT, Herblin WF, McDall DE, Ardecky RJ, Carini DJ, Duncia JV, et al. Identification of angiotensin receptor subtypes. Biochem Biophys Res Commun. 1989;165:196-203.
4. Bumpus FM, Catt KJ, Chiu AT, DeGasparo M, Godfraind T, Husain A, et al. Nomenclature for angiotensin receptors. A report of Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension. 1999;17:720-721.
5. Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol. 1997;59:395-412.
6. Noda K, Saad Y, Kinoshita A, Boyle TP, Graham RM, Husain A, et al. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J Biol Chem. 1995;270:2284-2289.
7. Bhuiyan MA, Ishiguro M, Hossain M, Nakamura T, Ozaki M, Miura S, et al. Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling. Life Sci. 2009;85:136-140.
8. Noda K, Feng YH, Liu XP, Saad Y, Husain A, Karnik SS. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. Biochemistry. 1996;35:16435-16442.
9. Feng YH, Miura S, Hussain A, Karnik SS. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). Biochemistry. 1998;37:15791-15798.
10. Feng YH, Ding Y, Ren S, Zhou L, Xu C, Karnik SS. Unconventional homologous internalization of the angiotensin II type-1 receptor induced by G-protein-independent signals. Hypertension. 2005;46:419-425.
11. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev. 2001;53:1-24.
12. Kohout TA, Leftkowitz RJ. Regulation of G-protein couple receptor kinases and arrestins during receptor desensitization. J Mol Pharmacol. 2003;63:9-18.
13. Lodowski DT, Pitcher JA, Capel WD, Leftkowitz RJ, Tesmer JJ. Keeping G-proteins at bay: a complex between G-protein couple receptor kinase 2 and Gbetagamma. Science. 2003;300:1256-1262.
14. Hertel C, Coulter S, Perkins JP. A comparison of catecholam-ineinduced internalization of beta-adrenergic receptors and receptor-mediated endocytosis of epidermal growth factor in human astrocytoma cells. Inhibition by phenylarsine oxide. J Biol Chem. 1985;260:12547-12553.
15. Waldo GL, Northup JK, Perkins JP, Harden TK. Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization. J Biol Chem. 1983;258:13900-13908.
16. Gagnon AE, Kallal L, Benovic JL. Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta2-adrenergic receptor. J Biol Chem. 1998;273:6976-6981.
17. Tsao P, Cao T, Von Zastrow M. Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol Sci. 2001;22:91-96.
18. Zhang J, Barak LS, Winkler KE, Caron MG, Ferguson SS. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem. 1997;272:27005-27014.
19. Claing A, Perry SJ, Achiriloaie M, Walker JK, Albanesi JP, Lefkowitz RJ, et al. Multiple endocytic pathways of G proteincoupled receptors delineated by GIT1 sensitivity. Proc Natl Acad Sci U S A. 2000;97:1119-1124.
20. Claing A, Laporte SA, Caron MG, Lefkowitz RJ. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and β-arrestin proteins. Prog Neurobiol. 2002;66:61-79.
21. Ferguson SS, Barak LS, Zhang J, Caron MG. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can J Physiol Pharmacol. 1996;74:1095-1110.
22. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 1998;38:289-319.
23. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem. 1998;273:18677-18680.
24. Pitcher JA, Freedman NJ, Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem. 1998;67:653-669.
25. 1 receptor activation. Nat Chem Biol. 2005;1:98-103.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
27. Miura S, Fujino M, Hanzawa H, Kiya Y, Imaizumi S, Matsuo Y, et al. Molecular mechanism underlying inverse agonist of angiotensin II type I receptor. J Biol Chem. 2006;281:19288-19295.
28. John H, Jennifer NH, Steven JF, Daniel KY. Identification of angiotensin II type 2 receptor domains mediating high-affinity CGP 42112A binding and receptor activation. J Pharmacol Exp Ther. 2001;298:665-673.
29. Miura S, Karnik SS. Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane helix-2. J Biol Chem. 2002;277:24299-24305.
30. 1 receptor. J Biol Chem. 1999;274:7103-7110.
31. Modrall JG, Nanamori M, Sadoshima J, Barnhart CB, Stanley JC, Neubig RR. ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling. Am J Physiol Cell Physiol. 2001;281:C801-C809.
32. 8) A-II by cultured bovine adrenocortical cells. Endocrinology. 1986;118:2312-2318.
33. 50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
34. 1 receptors. Biochem Pharmacol. 2003;65:1329-1338.
35. Miura S, Kiya Y, Kanazawa T, Imaizumi S, Fujino M, Matsuo Y, et al. Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol. 2008;22:139-146.
36. Pfeiffer R, Kirsch J, Fahrenholz F. Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp Cell Res. 1998;244:327-339.
37. Hunyady L. Molecular mechanisms of angiotensin II receptor internalization. J Am Soc Nephrol. 1999;10:S47-S56.
38. Houle S, Larrivee JF, Bachvarova M, Bouthillier J, Bachvarov DR, Marceau F. Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor. Hypertension. 2000;35: 1319-1325.
39. Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, Quirion R. Agonist- and antagonist-induced sequestration /internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol. 2003;139:695-704.